Personalis (PSNL) Preferred Stock Liabilities (2018 - 2019)
Personalis (PSNL) posted quarterly Preferred Stock Liabilities of $89.4 million for Q1 2019, little changed quarter-over-quarter from $89.4 million in Q4 2018.
Personalis (PSNL) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends
Personalis' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $89.4 million for Q1 2019.
- In Q1 2019, Preferred Stock Liabilities changed N/A year-over-year to $89.4 million; the TTM figure through Mar 2019 stood at $89.4 million (changed N/A YoY), while the FY2018 annual figure was $89.4 million, up 17.64% from the prior year.
- Preferred Stock Liabilities for Q1 2019 stood at $89.4 million, roughly flat from $89.4 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $89.4 million in Q3 2018, with the low at $76.0 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Personalis | 1.40 Bn | 1.17 Bn | 281,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 89.40 Mn |
| Dec 31, 2018 | 89.40 Mn |
| Sep 30, 2018 | 89.40 Mn |
| Jun 30, 2018 | 76.00 Mn |